Table 3 Relationship between refusal, recommendation, and receipt of adjuvant chemotherapy and characteristics of patients diagnosed with stage III colon cancer in Alberta between 2002 and 2005 who had an oncologist-consult

Gender:

P = 0.84

Female

27

(9)

48

(17)

208

(73)

283

(46)

Male

31

(9)

62

(19)

237

(72)

330

(54)

Age at diagnosis:

P < 0.0001

<65

10

(4)

11

(4)

232

(92)

253

(41)

65-69

5

(7)

6

(8)

60

(85)

71

(12)

70-74

11

(11)

13

(13)

76

(76)

100

(16)

≥ 75

32

(17)

80

(42)

77

(41)

189

(31)

Geographical regions:

P = 0.03

South

4

(9)

10

(22)

31

(69)

45

(7)

Calgary

8

(4)

40

(21)

143

(75)

191

(31)

Central

7

(7)

18

(19)

72

(74)

97

(16)

Edmonton

29

(13)

35

(16)

157

(71)

221

(36)

North

10

(17)

7

(12)

42

(71)

59

(10)

Distance from cancer facility

P = 0.97

< 90 km

49

(10)

94

(18)

369

(72)

512

(84)

90-180 km

5

(8)

9

(15)

47

(77)

61

(10)

> 180 km

4

(10)

7

(18)

29

(73)

40

(7)

Year of diagnosis:

P = 0.10

2002

8

(6)

26

(18)

109

(76)

143

(23)

2003

22

(13)

23

(14)

124

(73)

169

(28)

2004

17

(12)

26

(18)

100

(70)

143

(23)

2005

11

(7)

35

(22)

112

(71)

158

(26)

Median annual household income ^*

P = 0.01

< $37881

14

(12)

29

(25)

75

(64)

118

(20)

$37881 – $51057

15

(10)

29

(19)

110

(71)

154

(26)

$51058 - $67124

19

(12)

29

(19)

107

(69)

155

(26)

> $67124

9

(5)

20

(12)

143

(83)

172

(28)

% Living alone ^*

P < 0.0001

< 7%

20

(7)

36

(13)

218

(80)

274

(46)

7 – 24%

29

(19)

53

(19)

196

(71)

278

(46)

> 24%

8

(17)

18

(38)

21

(45)

47

(8)

Patient Characteristics

n

(%) ¹

n

(%) ¹

n

(%) ¹

n

(%) ²

% Not graduated from high school ^*

P = 0.50

< 27%

29

(9)

51

(16)

234

(75)

314

(52)

> 27%

28

(10)

56

(20)

201

(71)

285

(48)

% Employed ^*

P = 0.04

< 60%

16

(10)

40

(25)

101

(64)

160

(27)

60 – 71%

18

(8)

36

(17)

160

(75)

211

(35)

> 71%

23

(10)

31

(14)

174

(76)

228

(38)